Literature DB >> 35365950

Frequency of the PNPLA3 rs738409 polymorphism and other genetic loci for liver disease in a Guatemalan adult population.

Mariana Lazo1,2,3, Jiaqi Xie4, Christian S Alvarez5, Dominick Parisi6, Stephanie Yang4, Alvaro Rivera-Andrade7, Maria F Kroker-Lobos7, John D Groopman8, Eliseo Guallar8, Manuel Ramirez-Zea7, Dan E Arking4, Katherine A McGlynn5.   

Abstract

Entities:  

Keywords:  zzm321990PNPLA3zzm321990; Guatemala; Latinos; NAFLD; genetics

Mesh：

Substances：

Year:  2022        PMID： 35365950      PMCID： PMC9241623          DOI： 10.1111/liv.15268

Source DB:  PubMed          Journal:  Liver Int        ISSN： 1478-3223            Impact factor:   8.754


× No keyword cloud information.
  9 in total

1.  PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.

Authors:  Elizabeth K Speliotes; Johannah L Butler; Cameron D Palmer; Benjamin F Voight; Joel N Hirschhorn
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

2.  High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study.

Authors:  A Rivera-Andrade; M F Kroker-Lobos; M Lazo; N D Freedman; J W Smith; O Torres; K A McGlynn; J D Groopman; E Guallar; M Ramirez-Zea
Journal:  Nutr Metab Cardiovasc Dis       Date:  2018-10-31       Impact factor: 4.222

3.  What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes.

Authors:  J Zhang; K F Yu
Journal:  JAMA       Date:  1998-11-18       Impact factor: 56.272

4.  Racial and ethnic disparities in non-alcoholic fatty liver disease in the USA.

Authors:  Nicole E Rich; Mazen Noureddin; Fasiha Kanwal; Amit G Singal
Journal:  Lancet Gastroenterol Hepatol       Date:  2021-06

5.  Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.

Authors:  Ruben Hernaez; Jody McLean; Mariana Lazo; Frederick L Brancati; Joel N Hirschhorn; Ingrid B Borecki; Tamara B Harris; Thutrang Nguyen; Ihab R Kamel; Susanne Bonekamp; Mark S Eberhardt; Jeanne M Clark; Wen Hong Linda Kao; Elizabeth K Speliotes
Journal:  Clin Gastroenterol Hepatol       Date:  2013-02-13       Impact factor: 11.382

6.  Contribution of PNPLA3 gene to the natural history of liver diseases.

Authors:  E Trépo
Journal:  Acta Gastroenterol Belg       Date:  2017 Jan-Mar       Impact factor: 1.316

Review 7.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

8.  Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis.

Authors:  Soumik BasuRay; Yang Wang; Eriks Smagris; Jonathan C Cohen; Helen H Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-24       Impact factor: 11.205

9.  Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis.

Authors:  Guangrong Dai; Pengfei Liu; Xiaomei Li; Xiaoyan Zhou; Shuixiang He
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.